Trade SCTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Scribe Therapeutics Inc. (SCTX) is trading at US$33.00, up 2.68% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$643.84M. Over the past 52 weeks, SCTX has traded between US$15.00 and US$39.60. On Syfe you can trade SCTX with $0 commission and add it to your watchlist.
| Previous close | US$32.14 |
|---|---|
| Market cap | US$643.84M |
| 52-week range | US$15.00 – US$39.60 |
| Volume | 2.23M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Scribe Therapeutics Inc.
Scribe Therapeutics, Inc. is a clinical-stage biotechnology company. It is engaged in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded in June 2017 by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Alameda, CA.
Year: 2026
Guggenheim Initiates Scribe Therapeutics at Buy With $50 Price Target
Aug 18, 10:25 AM · MT Newswires
--Leerink Partners Initiates Scribe Therapeutics at Outperform With $37 Price Target
Aug 18, 10:24 AM · MT Newswires
--Wells Fargo Initiates Scribe Therapeutics at Overweight With $60 Price Target
Aug 18, 9:33 AM · MT Newswires
Scribe Therapeutics Inc. (SCTX) stock is trading at US$33.00, +2.68% from the previous close of US$32.14.
The market cap for Scribe Therapeutics Inc. (SCTX) stock is approximately US$643.84M.
The 52-week high for Scribe Therapeutics Inc. (SCTX) stock is US$39.60.
The 52-week low for Scribe Therapeutics Inc. (SCTX) stock is US$15.00.
Scribe Therapeutics Inc. (SCTX) does not currently pay a dividend.
Stay on top of SCTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
